Wednesday June 12, 2024
Sector in focus: Diagnostic imaging
This sector has seen a huge M&A boom as investors continue to consolidate particularly in Western Europe. Governments are also pumping money into the sector to increase access to diagnosis and bring down waiting times. Groups are adopting new models to integrate more services and offerings for the patient. The impact of digital transformation and AI is advanced in the sector particularly for efficiency and productivity. This session shares examples through case studies of how this innovation is driving quality and access and changing the business model and what this means for providers and investors
Speakers include:
Dr Arjun Kalyanpur, CEO, Teleradiology Solutions
Zisis Sotiriou, Group Chief Operating Office, evidia
Antoine Jomier, CEO & Founder, Incepto Medical
Moderated by Chris O’Donnell, Head of Content, HBI
Sector in focus: Diagnostic imaging
This sector has seen a huge M&A boom as investors continue to consolidate particularly in Western Europe. Governments are also pumping money into the sector to increase access to diagnosis and bring down waiting times. Groups are adopting new models to integrate more services and offerings for the patient. The impact of digital transformation and AI is advanced in the sector particularly for efficiency and productivity. This session shares examples through case studies of how this innovation is driving quality and access and changing the business model and what this means for providers and investors
Speakers include:
Dr Arjun Kalyanpur, CEO, Teleradiology Solutions
Zisis Sotiriou, Group Chief Operating Office, evidia
Antoine Jomier, CEO & Founder, Incepto Medical
Moderated by Chris O’Donnell, Head of Content, HBI
Speakers
Explore more sessions
View the agenda and see how this event will accelerate your business goals.
Explore similar sessions
Sector in focus: Lab diagnostics
With few consolidation opportunities remaining, the future for labs lies in organic growth and digitalisation. What will be the impact of automation and smart laboratories? Will self-testing take off massively?...
Sector in focus: Lab diagnostics
With few consolidation opportunities remaining, the future for labs lies in organic growth and digitalisation. What will be the impact of automation and smart laboratories? Will self-testing take off massively? Is there a threat from blood testing start-ups that are like Theranos, but work? This session features three laboratory diagnostic CEOs who share their approaches to growth.
Speakers include:
Joe Stringer, Executive Chairman, Automata
Case Study: The future of automation in labs, Automata, and The Royal Marsden
With the demand for genomic testing on the back of screening programs exploding, how are lab groups managing to keep up? Lab automation group, Automata has enabled providers such as a The Royal Marsden NHS Trust to increase genomic test throughput by 3 to 5x whilst simultaneously halving the space required. In this case study Joe explains how this was possible, the future of innovation in laboratories, the impact on the scientific workforce and productivity, and why logistics is now the only significant barrier to scaling innovation.
Speakers
How data and prevention is changing the laboratory business model
The global push for a preventative versus reactive approach to healthcare combined with digital technology is altering the business model for all healthcare providers. Each has the opportunity to leverage...
How data and prevention is changing the laboratory business model
The global push for a preventative versus reactive approach to healthcare combined with digital technology is altering the business model for all healthcare providers. Each has the opportunity to leverage their data to open up new revenue streams, cut costs and build better relationships with payors and directly with patients. For lab groups in particular, the valuable data generated through screening and routine testing presents an opportunity to replace the test volume that dipped after the pandemic. This session explores how lab services groups have found a way to monetise their data working with payors and how groups have an opportunity to open up new direct to consumer services and the role that technology is playing.
Speakers include:
Dr Matthew Prime, Global Medical Director, Roche Diagnostic Information Systems
Rick VanNess, Director, Product Group, Rhodes Group